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Functional proteomic analysisThe truncated phospholipids 1-palmitoyl-2-(5-oxovaleroyl)-sn-glycero-3-phosphocholine (POVPC) and 1-
palmitoyl-2-glutaroyl-sn-glycero-3-phosphocholine (PGPC) are oxidation products of 1-palmitoyl-2-
arachidonoyl phosphatidylcholine. Depending on concentration and the extent of modiﬁcation, these
compounds induce growth and death, differentiation and inﬂammation of vascular cells thus playing a role
in the development of atherosclerosis. Here we describe the import of ﬂuorescent POVPC and PGPC
analogs into cultured RAW 264.7 macrophages and the identiﬁcation of their primary protein targets. We
found that the ﬂuorescent oxidized phospholipids were rapidly taken up by the cells. The cellular target
sites depended on the chemical reactivity of these compounds but not on the donor (aqueous lipid
suspension, albumin or LDL). The great differences in cellular uptake of PGPC and POVPC are a direct
consequence of the subtle structural differences between both molecules. The former compound (carboxyl
lipid) can only physically interact with the molecules in its immediate vicinity. In contrast, the aldehydo-
lipid covalently reacts with free amino groups of proteins by forming covalent Schiff bases, and thus
becomes trapped in the cell surface. Despite covalent binding, POVPC is exchangeable between (lipo)
proteins and cells, since imines are subject to proton-catalyzed base exchange. Protein targeting by POVPC
is a selective process since only a limited subfraction of the total proteome was labeled by the ﬂuorescent
aldehydo-phospholipid. Chemically stabilized lipid–protein conjugates were identiﬁed by MS/MS. The re-
spective proteins are involved in apoptosis, stress response, lipid metabolism and transport. The identiﬁed
target proteins may be considered primary signaling platforms of the oxidized phospholipid.
© 2012 Elsevier B.V. Open access under CC BY-NC-ND license.1. Introduction
The uptake of oxidized LDL (oxLDL) by the macrophages of the
vascular wall is a hallmark of atherosclerosis [1]. This process is medi-
ated by the scavenger receptor and is not regulated. As a conse-
quence, massive amounts of lipid accumulate in these cells. The
macrophages change their phenotype and become foam cells, leading, bovine serum albumin; BY,
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etter).
-NC-ND license.to the formation of fatty streaks in the subendothelial space, an early
sign of the disease. The binding of oxLDL to the scavenger receptor is
driven by an increase in net negative charge on the particle surface
due to covalent modiﬁcation of apoB lysines by lipid aldehydes that
are oxidation products of polyunsaturated (phospho)lipids [2]. To
some extent, oxidized fatty acids and phospholipids containing free
carboxyl groups also contribute to this characteristic signature of
oxLDL. The harmful effects of oxLDL are not only associated with
lipid accumulation in macrophages and other vascular (smooth mus-
cle) cells (lipotoxicity). They are also mediated by the intrinsic toxicity
of a great variety of lipid oxidation products that are generated in LDL
under the conditions of oxidative stress (lipid toxicity) [3,4]. These
compounds comprise oxidized sterols, oxidized fatty acid derivatives
and oxidized glycerophospholipids. They have been found in plasma
LDL and in lipid deposits as well as lipoproteins isolated from athero-
sclerotic plaques [5]. The main phospholipid species in the LDL sur-
face contain linoleic and to a lesser extent arachidonic acid in
position sn-2 of glycerol [6]. Their oxidation products may contain a
modiﬁed long-chain carboxylic acid in this position or a truncated
acyl residue with a polar functional group at its ω-end. Typical
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hydophospholipids POVPC and Poxno-PC (from arachidonoyl- and lino-
leoyl phospholipids, respectively) and the carboxy-phospholipids PGPC
and Paze-PC (also from arachidonoyl- and linoleoyl phospholipids, re-
spectively). We found that sustained exposure towards μM concentra-
tions of both phospholipid classes induces apoptosis in vascular cells
including vascular smooth muscle cells [7] and macrophages (Stemmer
et al., unpublished data). Programmed cell death is mediated by cer-
amide which is formed as a consequence of the rapid activation of acid
sphingomyelinase, very likely on the protein level [8]. The same effects
were observed, when the cells were treated with minimally modiﬁed
LDL under the same conditions. This particle can be obtained bymild ox-
idation of LDL in vitro and is perhaps a reliable model for the oxidized
LDL formed in vivo. It is characterized by a high content of lipid oxidation
products and a low degree of protein modiﬁcation. Therefore, it is still
recognized by the LDL receptor. As a consequence its toxicity must be
largely due to the effects of its oxidized (phospho)lipid components.
Truncated phospholipids contain only a single hydrophobic long-
chain fatty acid in position sn-1 attaching the amphiphile to the hy-
drophobic domain of the bilayer. From molecular dynamics studies,
it can be inferred that the truncated sn-2 fatty acid folds back to the
aqueous phase (carboxylic-phospholipids) or the lipid–water inter-
face (aldehydo-phospholipids) [9]. Therefore, these compounds
show similar (supra)molecular features compared with other biolog-
ically active phospholipids, namely lysolecithin and platelet activat-
ing factor (PAF) [5].
Uptake and activity of oxidized phospholipids in cells have exten-
sively been discussed in the context of receptor-mediated processes.
Typical candidates are CD36 recognizing negatively charged motifs,
e.g. due to carboxy-phospholipids, or the PAF receptor with afﬁnities
for choline phospholipids containing short sn-2 acyl chains [10]. In
addition to the capacity of the oxidized phospholipids to interact
with receptors, their highly amphipathic character contributes to
their cellular activities. Unlike entirely water-soluble receptor li-
gands, they efﬁciently partition into phospholipid bilayers where
they can affect the functions of membrane-bound (signaling) pro-
teins either by direct interactions or in an indirect way by modulating
lipid dynamics and organization. Thus, it is more likely that oxidized
phospholipids encounter many primary targets representing primary
signaling platforms either in the plasma membrane or after rapid in-
ternalization inside the cells.
In this study we characterized the import of ﬂuorescent analogs of
the oxidized phospholipids POVPC and PGPC into cultured RAW 264.7
macrophages and identiﬁed their potential primary protein targets.
The ﬂuorescently labeled lipid analogs [11] were used as molecular
tools to visualize these processes and detect the lipid binding poly-
peptides. We found that the ﬂuorescent oxidized phospholipids
were rapidly taken up by the cells. Lipid import and localization
depended on the chemical reactivity of these compounds (aldehydo
versus carboxylate derivative). The lipid donor (aqueous lipid suspen-
sion, albumin, LDL) hardly showed any effect, pointing to the transfer
of single molecules between the donor and acceptor surfaces. Target-
ing of cellular proteins is a selective process since only a subfraction
of the total proteome was labeled. The respective lipid-associated
proteins may be considered primary signaling platforms of oxPL.
2. Materials and methods
2.1. Materials
Oxidized phospholipids (PGPC and POVPC) and their ﬂuorescent
analogs (BY-PGPE and BY-POVPE) were synthesized in our laboratory
as previously described [11]. Chemicals for gel electrophoresis were
from BioRad Laboratories (Hercules, CA), unless otherwise noted. Or-
ganic solvents and all other chemicals were purchased from Carl Roth
(Karlsruhe, Germany) or Sigma-Aldrich (Steinheim, Germany). Tissueculture materials were obtained from Sarstedt (Nümbrecht, Germany)
or Greiner (Kremsmünster, Austria). Dulbecco's modiﬁed Eagle's medi-
um and heat-inactivated fetal bovine serum were from Invitrogen
(Leek, Netherlands), and PBS and other cell culture supplements were
obtained from PAA (Linz, Austria), unless otherwise indicated.
2.2. LDL isolation and modiﬁcation
Human LDLwas isolated frompooled fresh plasma (a kind gift of Dr.
GholamAli Khoschsorur, UniversityHospital, Graz) by density ultracen-
trifugation in OptiSeal tubes using a Beckman NVT65 Rotor [12]. The
LDL fraction was collected and transferred into sterile septum vials
(TechneVials, Mallinckrodt, Germany) and stored at 4 °C until usewith-
in 2 weeks of isolation. Lipoprotein concentration is expressed in terms
of protein content, which was measured in a plate assay according to
the method of Bradford [13]. LDL was desalted using PD 10 columns
(GE Healthcare, Munich, Germany) prior to modiﬁcation or labeling
and diluted to 50 or 100 μg protein/ml, if not stated otherwise.Minimal-
ly modiﬁed LDL (mmLDL) was prepared as previously described [14].
LDL was incubated with 10 μM FeSO4 in sterile H2O at room tempera-
ture for 24 h. mmLDLwas desalted using PD 10 column (GE Healthcare,
Munich, Germany) prior to use.
2.3. Delivery systems for ﬂuorescently labeled oxPLs
Lipid dispersions containing 5 or 10 μM lipid in PBS buffer were pre-
pared using the ethanol injectionmethod [15]. The ﬁnal ethanol concen-
trations did not exceed 1% (v/v). Albumin-oxPL complexes (protein/
lipid=1/1 mol/mol) were prepared, using the same technique. For this
purpose, ethanolic solutions of oxPL were injected into solutions of BSA
in PBS under stirring at 37 °C. Concentration of ﬂuorescent oxPL was
5 μM. (mm)LDL-oxPL complexes (apoB100/oxPL=20/1 mol/mol) were
prepared by injection of ethanolic lipid solutions into LDL suspensions
(50 μg protein/ml) at 37 °C followed by incubation at room temperature
for 30 min. Total oxPL concentrations were 5 μM. Labeled LDL prepara-
tions were analyzed using native agarose gel electrophoresis (0.5% aga-
rose gel, 80 V). Fluorescently labeled LDL was visualized in-gel using a
Herolab imager (excitation wavelength: 365 nm) driven by EasyWin
software. Total protein was stained with Coomassie blue (0.02%, w/v).
Fluorescently labeled proteins in albumin and LDL preparations were
precipitated according to Wessel and Flügge [16], separated by SDS-
PAGE (4.5% stacking gel, 10% resolving gel) according to Fling and
Gregerson [17] and visualized using a BioRad laser scanner (Ex 488 nm,
Em 530/30 BP). Finally, total protein was stained using SYPRO Ruby™
(Invitrogen) according to manufacturer's instruction. SDS gels were
scanned for ﬂuorescence at 605 nm upon excitation with a 488 nm
laser. Incubations of the cells with pure lipid dispersions or lipid-carrier
complexes were performed in PBS or media without phenol red at
varying concentrations of FBS (0–10% v/v).
2.4. Cell culture
The macrophage cell line RAW 264.7 (ATCC No. TIB-71, American
Type Culture Collection, Rockville, MD, USA)was a kind gift fromDagmar
Kratky, Medical University of Graz, Austria. Cells were routinely grown in
DMEM (4.5 g/l glucose, 25 mM HEPES, 4 mM L-glutamine, without sodi-
um pyruvate) supplemented with 10% heat-inactivated FBS and
100 U/ml penicillin/streptomycin at 37 °C in humidiﬁed CO2 (5%)
atmosphere.
2.5. Fluorescence microscopy
Monolayer cultures of RAW 264.7 cells were grown to 60–80%
conﬂuency in Chamber slides (Nunc, Nalgene, Rochester USA). Cells
were incubated with aqueous dispersions of oxPLs or oxPL-carrier
complexes (total concentrations of ﬂuorescent oxPL were 5 or
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cells were carefully rinsed with PBS and observed with an Axiovert 35
inverted ﬂuorescence microscope equipped with a mercury-arc lamp
and a CCD camera, driven by AxioVision software package (Carl Zeiss,
Germany). BY-ﬂuorescence (Ex 505 nm, Em 510 nm) was detected
using the following ﬁlter set: excitation ﬁlter BP 450–490 nm, beam
splitter 510 nm and barrier ﬁlter LP 520 nm. Unlabeled cells were
used as a reference to examine autoﬂuorescence.
For ﬂuorescence colocalization experiments monolayer cultures of
RAW 264.7 cells were grown to 60–80% conﬂuency in Chamber slides
(Nunc, Nalgene, Rochester USA). Cells were incubated with 10 μM
oxPLs in PBS for 30 min. The labeled cells were rinsed twice with
PBS prior to incubation with 5 μg/ml Cellmask Deep Red plasma
membrane stain diluted in PBS (Invitrogen) for 10 min. Finally, cells
were washed three times with PBS and BY ﬂuorescence was observed
with an Axiovert 35 inverted ﬂuorescence microscope as described
above. Cellmask ﬂuorescence (Ex 649, Em 666) was detected using
the following ﬁlter set: excitation ﬁlter BP 575–625, beam splitter
645 and emission ﬁlter 660–710.
2.6. BY-POVPE exchange between cells, LDL and albumin
Solutions of BY-POVPE/LDL complexes in PBS (apoB/oxPL=20/
1 mol/mol, total oxPL concentration 5 μM) were desalted using PD
10 columns prior to incubation with 5 μM BSA solutions in PBS
(molar ratios of apoB100/albumin were 1:1, 1:5 and 1:10). The mix-
tures were incubated for 30 min at room temperature. Proteins
were precipitated according to the method of Wessel and Flügge
[16] and separated by SDS-PAGE [17] (4.5% stacking gel, 10%
resolving gel). Fluorescently labeled proteins were detected using a
BioRad laser scanner (Ex 488 nm, Em 530/30). Backtransfer of BY-
POVPE from cells to albumin was measured as follows: RAW 264.7
cells were grown to 60–80% conﬂuency in 100 mm Petri dishes and
treated with 6 ml of 5 μM ﬂuorescent lipid in PBS as described
above for 15 min. After washing the cells three times with PBS, 5 μM
BSA in PBS was added followed by incubation at 37 °C (5% CO2) for
15 min. The supernatant was isolated and the ﬂuorescent proteins
were separated by SDS-PAGE and imaged as described above.
2.7. Determination of protein targets of BY-POVPE
2.7.1. Separation of total cell proteins by 2-D electrophoresis
RAW 264.7 cells grown to 80% conﬂuency in 175 cm2 culture
ﬂasks were incubated with 10 ml 10 μM BY-POVPE dispersion in
PBS in the dark for 30 min. Labeled cells were washed twice with
cold PBS and scraped into 3 ml washing solution (PBS supplemented
with 100 mg/ml CaCl2, 10 mg/ml MgCl2, 1 mM PMSF and 50 μM
NaCNBH3). The following steps were performed at 4 °C. Cells were
centrifuged at 300 g for 3 min. The supernatant was discarded, fol-
lowed by cell lysis in 150 μl of lysis buffer, containing 20 mM
HEPES, 2 mM EDTA, 1% (v/v) Triton X-100 pH 7.4, 50 μM NaCNBH3,
1 mM PMSF, 10 μg/ml SBTI, 10 μg/ml leupeptin, for 1 h on ice. The
cell suspension was vigorously vortexed every 15 min. The lysate
was centrifuged at 1000 g for 5 min. NaCNBH3 was added to the su-
pernatant (ﬁnal concentration 100 μM). The resultant solution was
incubated at 37 °C for 2 h and stored at−20 °C. Protein concentration
was determined using a plate assay based on the method of Bradford
[13]. For 2-D PAGE on 20×20 cm gels, 500 μg protein was precipitat-
ed by TCA or according to the method of Wessel and Flügge [16]. The
protein pellet was solubilized in 340 μl rehydration buffer, containing
7 M urea, 2 M thiourea, 4% Chaps, 0.002% bromphenol blue and 2%
Pharmalyte™ 3–10, at 37 °C for 30 min. Sample solutions were ap-
plied to 18 cm immobilized pH gradient strips pH 3–10 (GE Health-
care, Munich, Germany). Strips were incubated over night at room
temperature in the dark. Isoelectric focusing and subsequent SDS-
PAGE were performed as previously described [18]. Electrophoreticseparation of proteins was performed using a PROTEAN II Multi cell
apparatus. After electrophoresis, gels were ﬁxed in aqueous solution
containing 10 vol.% EtOH and 7 vol.% AcOH, for at least 2 h. BY-
ﬂuorescence was detected using a BioRad laser scanner (Ex 488 nm,
Em 530/30 BP). Total proteins were stained with SYPRO Ruby™ (Ex
488 nm, Em 605 nm).2.7.2. Separation of membrane proteins by 1-D gel electrophoresis
RAW 264.7 cells grown to 80% conﬂuency in 175 cm2 culture
ﬂasks were incubated with 10 ml aqueous solutions of BY-POVPE in
the dark for 30 min. Labeled cells were washed twice with cold PBS
and scraped into 10 ml PBS and isolated by centrifugation at 300 g
for 5 min. The cell pellet was resuspended in 1 ml homogenization
buffer (0.218 M sucrose, 10 mM Tris/HCl, 1 mM EDTA, pH 7.4) and
separated by centrifugation at 450 g for 5 min. The pellet was resus-
pended in homogenization buffer (1.5 fold pellet volume) supple-
mented with aprotinin, pepstatin, leupeptin, (10 μg/ml each),
0.8 mM PMSF, 30 μg/ml cycloheximin and 50 μM NaCNBH3. The fol-
lowing steps were performed at 4 °C. Labeled cells were homogenized
using a glass–glass homogenizer. The extent of homogenization was
monitored by light microscopy. Homogenized cells were centrifuged
at 600 g for 10 min. The post nuclear supernatant (PNS) was centri-
fuged again at 600 g for 5 min. The PNS was diluted with homogeni-
zation buffer containing the protease inhibitors indicated above
(ﬁnal volume 800 μl) and the sample was transferred into Beckmann
centrifuge tubes (11×34) for ultracentrifugation (142,000×g) at 4 °C
for 1 h. The obtained supernatant represents the cytosolic fraction.
The membrane pellet was washed in 800 μl homogenization buffer
containing the protease inhibitors indicated above and centrifuged
at 117,000 g at 4 °C for 1 h. The membrane pellet was resuspended
in 200 μl homogenization buffer. NaCNBH3 (ﬁnal concentration
100 μM) was added to the PNS, the cytosolic fraction and the mem-
brane fraction followed by incubation at 37 °C for 2 h. Samples were
stored at −20 °C. For 1-D SDS-PAGE, protein concentration was
determined using a plate assay based on the method of Bradford
[13]. 100 μg protein of each sample was precipitated according to
Wessel and Flügge [16] and dissolved in 50 μl loading buffer [17].
The samples were applied onto a 20×20 cm SDS gel prepared and
separated according to the PROTEAN II xi cell protocol provided by
BioRad. Gels were ﬁxed over night in aqueous solutions containing
10 vol.% EtOH and 7 vol.% AcOH. BY-ﬂuorescence was imaged using
a BioRad laser scanner (Ex 488 nm, Em 530/30 BP). Total proteins
were stained with SYPRO Ruby™ as indicated above.
Inhibitory effect of POVPC on protein labeling with BY-POVPE:
a) Albumin labeling. An ethanolic solution of a mixture of POVPC/BY-
POVPE was injected into PBS containing 5 μM bovine serum albu-
min at room temperature under stirring for 30 min. Final lipid
concentrations were 0–100 μM POVPC and 5 μM BY-POVPE.
NaCNBH3 (ﬁnal concentration 10 mM) was added and imines
were reduced for 30 min. Protein separation and ﬂuorescence de-
tection on acrylamide gels were performed as described above.
b) Labeling of cell proteins. Cultured RAW macrophages (9×106
cells, 30 cm2) were incubated in DMEM without Phenol red, con-
taining 0.1% FCS and a mixture of POVPC (50 μM)/BY-POVPE
(5 μM). Labeled cells were washed with PBS containing 10 mM
NaCNBH3. Cells were scraped off and isolated by centrifugation
(300 g, 4 °C, 5 min). The cell pellet was resuspended in 500 μl
PBS containing 10 mM NaCNBH3 and disintegrated by pulsed
ultrasonication (15 pulses for 1 s) at 4 °C. After centrifugation
(1000 g, 4 °C, 10 min), the supernatant was isolated. After addi-
tion of NaCNBH3 (ﬁnal concentration 10 mM), the solution was
stirred at room temperature for 30 min. Protein separation and
ﬂuorescence detection on acryl amide gels were performed as de-
scribed above.
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Fluorescent BY-POVPE-protein complexes were excised from acryl
amid gels and tryptically digested according to the method of
Shevchenko et al. [19]. Peptide extracts were dissolved in 0.1% formic
acid and separated by nano-HPLC-system (ULTIMATE™ 3000 nanoLC
system, Dionex, Amsterdam, The Netherlands) as described [20], but
using the following gradient: solvent A: water, 0.3% formic acid;
solvent B: acetonitrile/water 80/20 (v/v), 0.3% formic acid; 0–5 min:
4% B, after 40 min 55% B, then for 5 min 90% B, and 47 min
reequilibration at 4% B. The peptides were ionized in a Finnigan
nano-ESI source equipped with Nanospray tips (PicoTip™ Emitter;
New Objective, Woburn, MA) and analyzed in a Thermo-Finnigan
LTQ linear iontrap mass-spectrometer (Thermo, San Jose, CA). The
MS/MS data were analyzed by searching the National Center for Bio-
technology Information nonredundant public database with Spek-
trumMill Rev.03.03.084 (Agilent, Darmstadt, Germany) software.
Acceptance parameters were two or more identiﬁed distinct peptides
according to Carr et al. [21]. Identiﬁed protein sequences were sub-
jected to BLAST and other public databases (NCBI, SwissProt, Expasy,
Brenda) to search for protein target candidates.
3. Results
We report on the cellular uptake and the primary molecular tar-
gets of a subclass of oxidized phosphatidylcholines. The respective
compounds contain a long-chain fatty acid in position sn-1 and a
short, polar, acyl chain in position sn-2 of glycerol thus roughly re-
sembling the chemical structure of platelet activating factor [5,4].
However, it has to be emphasized that the latter phospholipid exclu-
sively contains a short but unpolar acetyl residue at this position. Spe-
ciﬁcally, we compared two compounds showing the same structural
features except for the functional group at the ω-end of the sn-2
chain (Fig. 1). In PGPC, this is a carboxylate residue which renders
the entire molecule negatively charged. POVPC contains an aldehyde
function which is less polar but chemically reactive and thus can un-
dergo Schiff base formation with the free amino groups of proteins or
phospholipids [22]. In this study, we used BY-PGPE and BY-POVPE, as
ﬂuorescently labeled analogs of PGPC and POVPC respectively, carry-
ing a polar BY-ﬂuorophore linked to the polar lipid head groups
(Fig. 1) [11]. These compounds were used for visualization of lipids
in live cells and lipid–protein complexes in acryl amide or agarose
gels. In a previous study, we have provided evidence that they are re-
liable model compounds of their unlabeled counterparts [11].
Under physiological conditions, polar lipids can be transferred to
cells from different molecular and supramolecular systems such as
plasma proteins (albumin) and (low) density lipoproteins. Therefore,
we prepared and characterized different donors containing the ﬂuo-
rescent lipid analogs and investigated the transfer of the labeled lipids
from these systems to cultured macrophages using ﬂuorescenceFig. 1. Chemical structures of oxPLs and their ﬂuorescent analogs.PGPC: 1-Palmitoyl-2-glut
phospho-N-BODIPY™-ethanolamine. POVPC: 1-Palmitoyl-2-(5-oxovaleroyl)-sn-glycero-
BODIPY™-ethanolamine.microscopy. Conversely, we studied lipid transfer between the indi-
vidual donors and the back-transfer of the lipids from the cells to
the donors. Donor systems for our in vitro studies were deﬁned com-
plexes of the ﬂuorescent lipids with albumin and LDL as well as aque-
ous lipid dispersions as reference systems. Fig. 2 describes the
characterization of BY-POVPE complexes with LDL and albumin. Aga-
rose gel electrophoresis shows uniform bands of the ﬂuorescent LDL
(Fig. 2A). Fluorescence and protein detection demonstrate that the
electrophoretic mobility of the labeled particle is higher as compared
to unlabeled LDL. This effect is due to a more negative net charge
which is a consequence of covalent modiﬁcation of the LDL amino
groups by the phospholipid aldehyde. SDS electrophoresis supports
the assumption of an LDL-ﬂuorophore complex containing covalently
labeled apolipoprotein B (apo B) (Fig. 2B). No ﬂuorescence is seen in
apo B in SDS-PAGE after incubation with the carboxy lipid BY-PGPE
because lipid–protein interaction is noncovalent in this system. The
latter lipid can only be detected in LDL after running the labeled lipo-
protein under conditions of native agarose gel electrophoresis (data
not shown).
Both ﬂuorescent oxidized phospholipids form complexes with
serum albumin. This observation is in line with the afﬁnity of this pro-
tein for other phospholipids containing only one long-chain fatty acid
(e.g. lysophospholipids) [23]. BY-POVPE also forms a stable complex
with albumin which is detectable by ﬂuorescence imaging after SDS
gel electrophoresis (Fig. 2B). In order to observe phospholipid trans-
fer independent of receptor-mediated endocytosis, uptake of ﬂuores-
cent oxPL into the cells was studied under growth conditions, where
the LDL receptor was not expressed. BY-PGPE and BY-POVPE are
taken up into these cells in a very different manner (Fig. 3A). BY-
PGPE is quickly internalized. The amount of ﬂuorophore residing in
the plasma membrane must be negligible since only a small fraction
of the ﬂuorescent cellular lipid can be extracted by aqueous Triton
X-100 (data not shown). The mechanism of lipid uptake has already
been described in a previous publication. It has been shown that the
ﬂuorescent compound inserts into the plasma membrane followed
by cluster formation within milliseconds [24]. Eventually, the ﬂuores-
cent domains are internalized by endocytosis. BY-POVPE mainly lo-
calizes to the cell surface (colocalization with a plasma membrane-
speciﬁc dye; Fig. 3B), due to Schiff base formation with membrane
proteins and amino phospholipids. The lipid–protein complexes
were stabilized by chemical reduction and identiﬁed as putative pri-
mary targets of the phospholipid aldehyde (see below).
In summary, lipid uptake does not depend on the donor system.
The same cellular ﬂuorescence patterns were obtained if phospho-
lipids were released to the cells from pure lipid dispersions, lipid–
albumin complexes or lipid-loaded LDL (Fig. 3C). However, the
ﬂuorescence intensity of BY-PGPE inside the cells was signiﬁcantly
lower if labeled LDL was the lipid donor. This lipoprotein contains
PAF-acetylhydrolase which also catalyzes the degradation of short-aroyl-sn-glycero-3-phosphocholine. BY-PGPE: 1-Palmitoyl-2-glutaroyl-sn-glycero-3-
phosphocholine. BY-POVPE: 1-Palmitoyl-2-(5-oxovaleroyl)-sn-glycero-phospho-N-
Fig. 2. Characterization of molecular and supramolecular carriers of BY-POVPE (+ represents complexes labeled with BY-POVPE;− represents unlabeled references). Panel A. Aga-
rose gel electrophoresis (0.5%) of labeled LDL. LDL/BY-POVPE complexes (20/1, mol/mol; 5 μM label) show uniform bands with higher mobility of the labeled particle which is due
to a more negative net charge as a consequence of covalent modiﬁcation of amino groups by the aldehydo lipid. Panel B. SDS-PAGE of labeled LDL and BSA: LDL/BY-POVPE com-
plexes (20/1, mol/mol; 5 μM label) and BSA/BY-POVPE complexes (1/1, mol/mol; 5 μM label) show stable labeling of LDL protein and BSA by the aldehydo lipid. Fluorescent images
were obtained using a Herolab imager (panel A) or a BioRad laser scanner (panel B).
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partitioning more efﬁciently into the aqueous phase [25]. Exposure
to the ﬂuorescent oxPL analogs leads to slightly different cell sizes
and morphologies which is due to the different modes of lipid–cell in-
teractions. The aldehydophospholipid chemically binds to its molecu-
lar targets, whereas the carboxylate lipid does not.
Despite the fact that the lipid aldehyde BY-POVPE is ﬁrmly bound
to LDL and albumin, it is released from these carriers to the phospho-
lipids and proteins of the cell plasma membrane suggesting high re-
versibility of Schiff base formation. This observation prompted us to
study the transfer of the aldehydophospholipid between the individ-
ual donor systems LDL and albumin on the one hand and the release
of cellular phospholipid to albumin on the other hand. Fig. 4A shows
that BY-POVPE can be transferred from labeled LDL to unlabeled albu-
min in a concentration-dependent manner. After incubation of both
“donor” systems followed by SDS electrophoresis, the ﬂuorescence
can be seen both in the apoB and the albumin band. The emission in-
tensity correlated with the amount of albumin in the incubation mix-
ture. Release of BY-POVPE from LDL is signiﬁcantly reduced after
treatment with NaCNBH3 leading to the formation of stable amine
bonds (data not shown). If cells labeled with BY-POVPE were incubat-
ed with unlabeled albumin, the same phenomenon was observed
(Fig. 4B). The lipid ﬂuorescence was detectable in the albumin band
after SDS gel electrophoresis. The partitioning of the aldehydopho-
spholipid between the different biological surfaces would be in line
with the assumption that a signiﬁcant fraction of the imines in the
protein–lipid complexes is protonated and therefore prone to nucleo-
philic attack by other amines in the sample. In the literature, a pKvalue around 7 has been reported for aliphatic Schiff bases [26]. The
accurate pK values of the imine groups in POVPC conjugates with
the target proteins found in this study are unknown and have to be
determined. They may vary depending on the individual protein
component.
We isolated and identiﬁed the protein targets of BY-POVPE in cul-
tured macrophages, which are expected to form covalent Schiff base
adducts (Fig. 5). Because the imine complexes are unstable, they
have to be stabilized before isolation and separation by chemical re-
duction leading to the formation of the stable amines. We used a pro-
teome approach to identify the lipid binding proteins in total cell
lysates as well as in the total membrane fractions. For this purpose,
the cells were incubated with the ﬂuorescent lipid, followed by lysis
and isolation of total membranes by centrifugation. Proteins of total
cell lysates were separated by 2-D PAGE (Fig. 6A), whereas the total
membrane fraction was subjected to 1-D SDS electrophoresis
(Fig. 6B). The ﬂuorescent protein spots/bands were excised and tryp-
tically digested followed by MS/MS analysis of the peptides. Fig. 6A
and B show that the ﬂuorescence patterns reﬂecting the labeled pro-
tein targets are much less complex than the total protein patterns
detected after SYPRO Ruby™ staining. Obviously, the protein target-
ing by the oxidized phospholipids is selective rather than random.
This effect may be due to the different pK values of differently ex-
posed amino groups and steric constrains as a consequence of differ-
ent lipid–protein and protein–protein interactions in the membrane.
The speciﬁc protein targeting by BY-POVPE is underscored by the
data shown in Fig. 6B. The ﬂuorescence image shows the protein tar-
gets of the phospholipid aldehyde in membranes depending on
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concentrations lead to uniformly higher ﬂuorescence intensities of
the individual bands, but the ﬂuorescence pattern is always the
same. Obviously, protein modiﬁcation by BY-POVPE is a selective pro-
cess. According to the data in Tables 1 and 2, it affects polypeptides
involved in membrane transport (e.g. VDAC), stress response (e.g.
heat shock proteins), apoptosis (e.g. cathepsin D, caspases) and lipidmetabolism (e.g. N-acyl-sphingosine hydrolase) (Tables 1 and 2). In
the membrane fraction and especially in the total cell lysate, we do
not only ﬁnd membrane but also cytosolic proteins. These targets
may be labeled by a small fraction of lipid entering the cell interior.
Once a cytosolic protein is alkylated by the aldehydophospholipid, it
becomes associated with lipid bilayers and, as a consequence, shows
up in the membrane pellet after ultracentrifugation.
In order to ﬁnd out whether the protein complexes of ﬂuorescent
BY-POVPE reﬂect the interactions of unlabeled POVPC, competition
experiments were performed (Fig. 7). Bovine serum albumin (panel
A) or cultured RAW 264.7 cells (panel B) were incubated with mix-
tures of BY-POVPE and POVPC. Fluorescence labeling of albumin
was suppressed by POVPC in a concentration-dependent manner.
Fluorescence labeling of protein targets in live cells was also abol-
ished by the unlabeled lipid. It seems that the ﬂuorescence of BY-
POVPE is less easily suppressed by POVPC in albumin than in RAW
cell proteins at the same ratio of labeled to unlabeled lipid. It remains
to be clariﬁed why this protein and presumably other isolated pro-
teins are modiﬁed by amphipathic lipid aldehydes to a different ex-
tent as compared to polypeptides in the complex (supra)molecular
environment of live cells. We conclude that ﬂuorescently labeled
BY-POVPE is a useful analog of POVPC. This assumption is also sup-
ported by ﬁndings of other laboratories (see Discussion).
4. Discussion
Sustained exposure of cultured vascular cells to the truncated ox-
idized phospholipids PGPC and POVPC leads to apoptotic cell death. A
couple of receptors have so far been discussed as primary signaling
platforms propagating the toxic lipid effects. Since both compounds
are structurally related to platelet activating factor (PAF), they show
binding afﬁnities for the PAF receptor [27]. Other receptor candidates
have also been suggested including TLR-2 and CD 36 [28]. The latter
protein preferably binds lipid or protein domains with net negative
charges and therefore is a receptor candidate for PGPC. This assump-
tion is underlined by the Whisker model suggested by Greenberg et
al. [29]. According to this hypothesis, oxidized phospholipids mainly
inﬂuence the properties of membrane surfaces via their polar acyl
chains which protrude into the aqueous phase. This assumption has
meanwhile been supported by molecular dynamic studies by Khan-
delia and Mouritsen on Paze-PC and Poxno-PC that are longer chain
homologs of PGPC and POVPC, respectively [9].
Although many cellular effects of oxidized phospholipids are me-
diated by receptors it is unlikely that speciﬁc receptor binding is the
only primary event responsible for lipid activity. In contrast to
water-soluble peptides or small molecules as receptor ligands, (oxi-
dized) phospholipids are amphipathic and as a consequence easily
partition into the plasma membrane bilayer where they can elicit sig-
naling effects on the molecular and supramolecular level. On the one
hand, they can undergo bimolecular interactions with several pro-
teins (enzymes) or, on the other hand, perturb a larger membraneFig. 3. Uptake of oxPLs by RAW 264.7 macrophages from different carriers. Panel A:
Fluorescence micrographs (320×) of RAW 264.7 cells incubated with oxPL (5 μM) sus-
pensions in PBS over 5 and 30 min. BY-oxPLs ﬂuorescence is detected in the plasma
membrane after 5 min incubation time. BY-PGPE is rapidly internalized by the cells.
In contrast, BY-POVPE stays much longer in the plasma membrane due to formation
of covalent adducts with free amino groups of proteins and lipids. Panel B: Image sec-
tion of ﬂuorescence micrographs (320×) of RAW 264.7 macrophages incubated with
ﬂuorescent oxPL (10 μM, suspension in PBS). After incubation cells were stained with
Cellmask Deep Red plasma membrane (PM) stain (5 μg/ml in PBS) for 10 min. BY-
POVPE, but not BY-PGPE colocalized with the plasma membrane stain. Panel C: Fluo-
rescent micrographs (320×) of RAW 264.7 cells pre-incubated with BY-oxPL labeled
BSA or LDL for 30 min. Similar patterns are found for oxPL uptake from different car-
riers. In case of BY-POVPE most of the ﬂuorescence is detected in the plasma mem-
brane where the ﬂuorescent POVPC analog is captured by proteins and lipids. Only
low amounts of the ﬂuorescent PGPC analog are taken up by the cells from LDL or
mmLDL. These low apparent uptake efﬁciencies are due to prior oxPL degradation in
the lipoprotein. No autoﬂuorescence was detected in unlabeled control cells.
Fig. 4. Transfer of BY-POVPE between lipid donors— reversibility of Schiff base formation in BY-POVPE-protein complexes. Panel A: LDL/BY-POVPE complexes were incubated with
various amounts of BSA followed by protein separation using SDS-PAGE. Fluorescence imaging of labeled lipid–protein complexes on SDS gels shows that BY-POVPE is transferred
from LDL to bovine serum albumin in a concentration-dependent manner, indicating that Schiff base formation between BY-POVPE and its targets is reversible. LDL has a higher
capacity than BSA for accommodating BY-POVPE (apoB and phospholipid monolayer). BY-POVPE exchange between the following systems was studied (mol LDL refers to the
molar amounts of apoB100). Lane 1: LDL-BY-POVPE: BSA 1:1 mol/mol; lane 2: MW standard; lane 3: LDL-BY-POVPE: BSA 1:5 mol/mol; lane 4: LDL-BY-POVPE: BSA 1:10 mol/mol;
lane 5: LDL reference. Panel B: RAW 264.7 cells were incubated with BY-POVPE (10 μM) or without label (blank sample) for 15 min followed by extensive washing with PBS and
adding of 10 μM BSA solution. This mixture was incubated for 15 min. The BSA containing supernatant of BY-POVPE treated (lanes 1 and 3) or blank samples (lanes 2 and 4) was
collected and split into two aliquots. One sample was incubated under reducing conditions for 30 min to stabilize the Schiff base. The proteins were precipitated and separated by
SDS gel electrophoresis prior to detection of ﬂuorescence by laser scanning and protein staining with Coomassie blue. Without reductive stabilization of the Schiff base the same
results were obtained, but the ﬂuorescence intensities were much weaker. Lanes 1 and 2: 20 μg protein; lanes 3 and 4: 40 μg protein; lane 5: MW standard. Lanes 1 and 3 show that
BY-POVPE is back-transferred from the cell surface to BSA. Fluorescence intensities depend on lipid acceptor concentration. The slight autoﬂuorescence of BSA in lanes 2 and 4 is due
to the emission of bound bilirubin.
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Sustained protein activation can be evoked by the phospholipid alde-
hyde POVPC. This compound alkylates proteins by Schiff base formation
thereby improving their association and interaction with membrane
bilayers. Typical functional consequences have already been demon-
strated by Kinnunen and colleagues. They found that Poxno-PC, a
longer chain homologue of POVPC, improved phospholipase A2 ac-
tivity in artiﬁcial membranes and abolished the lag time that isusually observed with interfacially active enzymes [30]. Other alde-
hydes have also been shown to activate membrane proteins in a co-
valent manner. For instance, modiﬁcation of the epidermal growth
factor receptor by hydroxynonenal mimics binding of its natural li-
gand thereby triggering speciﬁc signaling cascades [31,32]. Finally,
plasmamembrane-bound oxidized phospholipidsmay be released inside
the cells where they can inﬂuence a number of other proteins/enzymes
directly.
Fig. 5. Covalent interaction of POVPC with protein and lipid targets.The aldehyde group
at the truncated sn-2 chain of POVPC forms a covalent Schiff base with free amino
groups of proteins and presumably aminophospholipids (PE and PS). Since Schiff
bases are unstable, the imines are chemically reduced to the stable amines for further
analysis.
Fig. 6. Protein targets of ﬂuorescent BY-POVPE in RAW 264.7 macrophages.Panel A: Cells we
tive conditions to stabilize the lipid–protein complexes (Schiff bases). The labeled proteins
were imaged using a ﬂuorescence laser scanner (BioRad). The lipid stain represents the pr
the full cell proteome. The ﬂuorescence patterns show that the staining of the protein targets
Panel B: Cells were incubated with different concentrations of BY-POVPE in PBS over
(>100,000×g). The membrane pellets were isolated and resuspended in PBS prior to pro
the cells with the oxPL, all procedures were performed under reductive conditions (see ab
The lipid stain represents the proteins covalently attached to the ﬂuorescent oxPL. BY-PO
5 μM; lane 4: 0 μM, shows only autoﬂuorescent proteins; lane 5: SYPRO Ruby™ full prote
the BY-POVPE-labeled protein targets depend on lipid concentration and leveled off at 5 μM
by the amount of BY-POVPE.
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acid. As a consequence, they are highly exchangeable between lipid–
water interfaces. Therefore, it is likely that the biological activities of
PGPC and POVPC are due to multiple lipid–protein or lipid–lipid in-
teractions rather than speciﬁc binding to a couple of receptors. In
this study, we used ﬂuorescently labeled derivatives of PGPC and
POVPC to measure lipid uptake into cultured RAW 264.7 macro-
phages and identify their primary protein targets. The ﬂuorescent
lipids contained a BY-ﬂuorophore bound to the polar head groups.
They are reliable analogs of their natural counterparts. It has already
been shown by the group of Berliner that the biological activities of
truncated phospholipids are mainly determined by the structure of
the polar sn-2 acyl chain and to a much lesser extent by the structure
of the polar heads [33]. We found that proper labeling of oxidized
phospholipids did not signiﬁcantly alter their signaling effects. Head
group-labeled analogs and unlabeled lipids elicited the same activa-
tion of acid sphingomyelinase generating the apoptotic lipid messen-
ger ceramide [8,11]. A comparative study on the inﬂammatory
response of vascular cells towards oxidized phospholipids and their
biotin-labeled analogs also provided evidence that head-group label-
ing is not critical [34]. All these observations are in agreement with
the assumption that the truncated oxidized phospholipids mainly
“communicate” at the membrane surface via their polar sn-2 acyl
chains (see above).re incubated with BY-POVPE (10 μM) in PBS for 30 min followed by lysis under reduc-
were precipitated and separated by 2-D SDS gel electrophoresis. Fluorescent proteins
oteins covalently attached to the ﬂuorescent oxPL. The SYPRO Ruby™ stain represents
by BY-POVPE is a selective process affecting only a deﬁned subset of the cell proteome.
30 min followed by separation of the membrane fraction using ultracentrifugation
tein precipitation and separation by 1-D SDS gel electrophoresis. After incubation of
ove). Fluorescent proteins were imaged using a ﬂuorescence laser scanner (BioRad).
VPE concentrations in the incubation mixtures: lane 1: 1 μM; lane 2: 2.5 μM; lane 3:
in stain of one representative lane, lane 6: MW standard. Fluorescence intensities of
lipid. The ﬂuorescent patterns and therefore the selectivity of labeling were unaffected
Table 1
Protein targets of BY-POVPE in total RAW 264.7 macrophage lysates. Highlighted proteins have also been found in the membrane fractions (Table 2). Cells were incubated with
BY-POVPE (10 μM) in PBS for 30 min followed by lysis and 2-D SDS gel electrophoresis. Spots (Fig. 6 panel A) were excised and tryptically digested. Subsequently, peptides were
analyzed by MS/MS and targets were identiﬁed by database search (NCBI, Expasy, SwissProt, Brenda).
Spot Spectra Distinct Distinct Summed AA Protein Protein Database ID Protein Name
Peptides MS/MS Search Coverage MW [Da] pI Accession GI 
(#) (#) (#) Score [%] (#)
1 8 5 49.09 11 46798.50 5.97 26347479 sorting nexin 5
1 12 4 44.93 11 45771.10 6.23 148709540 leupaxin
2 154 25 384.54 35 92490.30 4.74 14714615 Heat shock protein 90kDA beta (Grp94)
3 8 4 53.45 10 48021.80 4.34 74227675 calreticulin
4 467 32 550.23 53 72422.40 5.07 2506545 78kDa glucose reulated protein precursur
5 173 20 336.08 36 70947.50 5.37 74198978 Dank-type molecular chaperone hsp72-ps1
5 37 10 158.11 19 72416.70 5.83 74192747 arginyl aminopeptidase
6 255 14 246.43 26 73528.70 5.91 6754256 heat shock protein 9 grp 75 Hsp709A
7 371 24 400.41 44 70947.50 5.37 74198978 Dank-type molecular chaperone hsp72-ps1
7 34 7 122.94 14 68368.50 5.42 31560731 ATPase. H+ transporting. lysosomal V1 subunit A
8 9 3 48.82 11 39370.90 4.95 148686207 lymphocyte specific 1
9 14 8 134.39 16 72477.50 5.10 2598562 BiP Hsp70 protein GRP78
9 6 3 40.65 6 57079.20 5.88 149023098 protein disulfid isomerase associated 3
10 70 14 190.29 31 56775.30 5.89 148691054 ubiquitin- specific peptidase 14
10 65 13 185.40 27 61054.90 6.07 51766670 heat shock protein 1 (chaperonin)
10 14 4 46.81 6 58928.90 5.48 74214557 copine I
11 202 7 120.29 21 45002.10 5.42 148673963 mCG13192 p47 protein
12 11 5 66.67 16 38358.20 5.17 6754910 mCG19035, nudC nuclear distribution gene C
12 3 2 22.20 4 53711.20 5.12 74184979 ataxin10
13 7 5 64.87 19 37402.30 5.06 7305121 glycogenin
14 21 7 111.06 21 38358.20 5.17 6754910 mCG19035. nudC nuclear distribution gene C
15 10 3 46.74 8 45565.50 5.86 74212703 RasGAP-associated protein p56dok-2
16 67 13 202.10 31 51146.80 5.49 70794778 RuvB-like 2
16 22 4 64.72 12 48374.20 6.85 26354406 cathepsinD
17 12 4 53.33 12 393514.00 5.44 27370510 paraoxonase3
17 5 2 35.39 6 37719.60 5.61 148683063 guanine nucleotide binding protein
18 3 3 33.73 10 35930.00 5.43 33416530 Annexin A4
19 27 11 139.71 26 51777.80 5.58 18017596 sorting nexin 4
19 50 10 133.75 20 57538.20 5.57 74191447 vacuolar H+ATPase B2
20 43 9 120.41 19 56585.90 8.30 5235955 3-phosphoglycerate dehydrogenase
21 13 5 66.45 9 72613.90 7.06 74219241 succinate dehydrognease Fp subunit
22 59 6 75.52 11 60630.40 6.28 6753320 chaperonin subunit 3
22 123 4 56.40 7 72613.90 7.06 74219241 succinate dehydrognease Fp subunit
23 75 12 203.43 24 75801.50 8.30 148704343 phosphoenolpyruvate carboxykinase 2
23 8 4 52.80 7 72613.90 7.06 74219241 succinate dehydrognease Fp subunit
24 4 2 26.11 5 46762.20 5.86 148704797 sorting nexin 6
24 11 6 83.96 15 45640.70 5.73 86198305 caspase1
25 3 2 25.95 5 44669.80 8.86 9790019 N-acyl sphingosine amidohydrolase
26 22 6 88.00 22 31746.00 7.44 33243895 voltage dependent anion channel2 VDAC-2
26 10 3 41.70 16 31475.00 6.46 6753284 caspase3
27 8 3 42.05 16 22236.70 8.26 12846314 peroxiredoxin1
28 5 2 29.80 6 36856.50 4.72 7106546 LOC298795 protein, similar 14-3-3 sigma
29 14 4 65.88 15 29965.70 8.25 74185553 Tat-interacting protein TIP30
29 3 2 30.52 7 32577.80 7.67 74212025 voltage dependent anion channel  VDAC-1
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to study the time-dependent lipid uptake and localization in live cells
reducing the probability of artefacts. In a previous study on the im-
port of biotin-tagged oxidized phospholipids into HAEC, cell ﬁxation
was required for lipid localization by secondary ﬂuorescence staining
of biotin [34]. This stabilization is based on cross-linking by aldehydes
which affects and perturbs (subcellular) membrane assemblies.
In agreement with previous studies, the ﬂuorescent PGPC analog
was quickly internalized by the cells [24]. In contrast, POVPC was
retained in the plasma membrane since it contains an aldehyde
group which can form covalent Schiff bases with the amino groups
of proteins and phospholipids. It is striking, especially in the case of
POVPC, that delivery of the labeled phospholipids analogs to the
cells did not depend on the lipid donor (aqueous lipid dispersions
and lipid complexes with albumin and LDL).
Lipid complexes with albumin and LDL are likely to be physiological-
ly relevant donors of oxidized phospholipids in vivo. LDL is a site of lipid
oxidation. Albumin may extract oxidized phospholipids from the parti-
cle, since it shows binding afﬁnities for phospholipids containing only
one long hydrophobic fatty acid, e.g. lysolecithin [23]. We were able to
show that both carriers form stable complexeswithﬂuorescent oxidizedphospholipids also (Fig. 2). Whereas PGPC only physically binds to pro-
teins and lipoproteins, POVPC is covalently linked to these carriers.
However, regardless of covalent binding, the POVPC analog is released
from these donor systems to cells and vice versa. In addition, it is freely
exchangeable between the individual donors. This exchangeability is
due to the instability of the covalent lipid adducts. The pK-values for
Schiff bases around7 [26]make the imines prone to protonation andnu-
cleophilic substitution by other amines. As a consequence, short-chain
oxidized phospholipids, including phospholipid aldehydes, are not
only active at the site of their formation but can be spread as “signal
transducers” to the near cellular environment by diffusion within the
tissues as well as to tissues far distant from the site of oxidative stress
via the circulation. The relevance of such processes has already been
underscored by the identiﬁcation of small particles in the circulation
that are enriched in oxidized phospholipids [35,36].
We screened for the primary protein targets of aldehydophospholi-
pids in cultured macrophages using a ﬂuorescent POVPC analog. This
phospholipid forms covalent Schiff bases that can be stabilized by
chemical reduction for further protein separation, detection and analy-
sis. In contrast to our “expectations”, protein labeling by this compound
was selective (Fig. 6). A ﬂuorescence image of the phospholipid-tagged
Table 2
Protein targets of BY-POVPE in the total membrane fraction of RAW 264.7 macrophages. Membrane-associated proteins are highlighted. Cells were incubated with BY-POVPE
(5 μM) in PBS for 30 min followed by the isolation of the total membrane fraction and 1-D SDS gel electrophoresis of the proteins. Bands (Fig. 6 panel B) were excised and
tryptically digested. Subsequently, peptides were analyzed by MS/MS and targets were identiﬁed by database search (NCBI, Expasy, SwissProt, Brenda).
Band Spectra Distinct Distinct Summed AA Protein Protein Database ID Protein Name
Peptides MS/MS Search Coverage MW [Da] pI Accession GI 
(#) (#) (#) Score [%] (#)
1 68 20 328.08 5 534218.4 5.74 122065897 Plectin-1
1 56 18 293.94 4 532048.3 6.03 134288917 dynein, cytoplasmic, heavy chain-1
2 138 21 357.47 10 272134.3 5.92 49022858 talin 1, isoform CRA_b
2 25 5 81.7 2 274938.7 6.16 148702862 fatty acid synthase, isoform CRA_b
2 3 2 25.43 1 125954.4 6.92 148704174 ATPase, aminophospholipidtransporter-like, class I
3 47 10 149.35 14 92771.4 4.72 14714615 rCG49111- Hsp90kDa beta (Grp94), member1
3 49 7 107.49 9 113054.9 5.30 6978543 ATPase, Na+/K+ transporter, alpha1 polypeptide
3 30 15 253.46 17 123093.4 5.72 38604071 exportin
3 14 3 55.49 4 91048.2 5.26 148670554 valosin
3 3 2 36.05 4 85026.4 7.02 3183523 Integrin beta 2 precursor
4 33 7 114.46 11 84816.3 4.93 74147335 heat shock protein 1. alpha
4 29 12 203.06 21 67278.3 4.50 6671664 calnexin
5 140 28 482.63 45 83341.8 4.97 51859516 Hsp90
5 22 11 184.59 17 86295.4 7.02 148666539 inner mebrane protein
5 19 7 97.68 15 53748 5.06 74199770 vimentin
6 28 9 142.87 12 86295.4 7.02 148666539 inner membrane protein , mitochondrial
7 80 25 440.32 39 74300 6.54 12835914 Lamin A isoform A
7 39 16 277.7 28 70208.7 5.12 74139671 lymphocyte cytosolic protein 1
7 36 15 248.36 31 74570 8.43 27369581 solute carrier family 25
7 51 14 240.71 25 72613.9 7.06 74219241 succinate dehydrogenase Fp subunit
7 13 6 94.56 11 70947.5 5.38 74198978 Dank-type molecular chaperone hsp72-ps1
7 9 4 59.81 7 68528.7 6.02 48474583 Dolichyl-diphosphooligosaccaride-protein GT
7 7 2 32.39 4 71376.8 7.92 56550045 spleen tyrosin kinase
7 3 3 36.85 4 70208.7 5.12 7413967 65-kDa macrophage protein
7 2 2 26.97 3 69311.5 5.73 50510565 SWA-70 protein
8 262 28 500.67 62 57846.2 6.66 74221210 pyruvate kinase
8 29 11 199.54 27 59684.6 7.95 74151643 T-complex protein 1 subunit
8 22 14 218.65 28 58104.7 6.46 74204595 chaperonin subunit 6a
8 19 9 125.33 18 53748 5.06 74199770 vimentin
8 18 5 80.47 9 58084.7 8.24 74204209 chaperonin subunit 4 (delta)
8 13 8 123.87 19 56678.7 5.88
5.88
112293264 protein disulfid isomerase associated 3
8 6 2 30.56 4 57079.2 149023098 protein disulfid isomerase associated 3
8 5 3 41.14 8 57987.6 5.37 31543458 p21-activated kinase 2
9 165 18 343.58 49 56667.1 5.24 23272966 Atp5b protein
9 302 32 563.07 65 53687.9 5.06 31982755 vimentin
9 76 17 312.48 50 53811.8 8.10 148698452 CAP, adenylat cyclase-associated protein 1
9 72 17 244.43 36 53688.9 5.04 74139645 vimentin
9 62 19 345.6 53 57477.6 5.97 126521835 chaperonin subunit 2
9 53 17 300.52 38 59766.9 9.22 74211072 ATP synthase, H+ transporting
9 22 10 186.6 27 57538.2 5.58 74191447 vacuolar H+ ATPase B2
9 12 5 74.71 8 65442.5 9.27 50510859 sphingosine phosphate lyase
9 3 2 27.37 5 54305.1 8.28 16758554 phosphadidylinositol 4-kianse type2 alpha
10 18 5 74.8 12 51737 8.72 13385942 citrate synthase
10 10 3 54.98 11 48374.2 6.86 26354406 cathepsin D
11 232 5 82.95 18 33312.5 9.83 61556754 prohibitin 2
11 101 4 72.92 17 31746 7.44 13786202 voltage dependent anion channel 2
12 84 5 87.14 22 32351.6 8.55 10720404 voltage dependent anion channel 1
12 33 5 85.21 18 35148 7.60 74207645 guanine nucleotide binding protein
13 86 8 122.73 26 32931.5 9.74 22094075 solute carrier family 25, member 5
13 27 9 149.32 31 35096.8 5.36 74215924 14-3-3 gamma
13 12 6 118.01 33 29087.8 4.71 148676868 14-3-3 zeta
13 9 5 85.39 25 30884.1 8.96 5980769 voltage dependent anion chanel 3
13 8 2 38.55 11 25067.2 6.10 123234567 tumor protein D52-like 2
14 15 3 38.22 8 31611.1 9.20 148697937 B-cell receptor- associated protein 31
15 30 3 57.65 11 32191.9 5.57 148667347 Triphosphatisomerase
15 30 2 39.68 10 26927.2 4.92 70608194 tumor protein D52-like 2
16 22 2 41.4 12 31440.6 6.54 975689 stomatin
16 20 3 45.81 13 23927.1 5.85 16758368 RAB 14, member Ras oncogen family
17 15 5 92 25 22541.1 8.58 7710086 RAB 10, member Ras oncogen family
17 7 2 25.36 7 28144.9 9.55 148687100 RAS-related C3 botulinum substrate 1
18 320 4 54.53 16 20246.8 11.39 30061401 histone cluster 2, H3c1 isoform 2
18 42 3 53.13 28 11651 4.42 83745120 ribosomal protein, large P2
19 461 6 96.76 40 16572.4 10.13 149029297 histone 1, H2bn
19 127 3 59.3 30 14759 9.21 6677775 ribosomal protein L22
20 54 2 38.49 15 17748.7 10.85 149263957 ribosomal protein S18
21 152 5 90.57 32 17239.2 10.59 94378251 similar to histone 4
22 11 2 32.61 21 9326.8 9.52 33563266 NADH dehydrogenase 1 alpha subcomplex
23 58 2 35.12 21 9326.8 9.52 33563266 NADH dehydrogenase 1 alpha subcomplex
24 8 3 44.93 5 56505.3 5.10 57012436 keratin 10
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Fig. 7. Inhibitory effect of POVPC on Schiff base formation of BY-POVPE with proteins.Incubation of albumin and RAW cells with BY-POVPE-POVPC mixtures, isolation and separation
and ﬂuorescence detection of labeled proteins were performed as described in the Materials and methods section. Shown are the ﬂuorescence images of labeled proteins after SDS
gel electrophoresis. Lipid stain: ﬂuorescence of proteins labeled with BY-POVPE. Total protein stain: ﬂuorescence of protein-bound SYPRO Ruby™. Panel A: ﬂuorescence labeling of
albumin. Panel B: ﬂuorescence labeling of RAW cell proteins. In both cases, unlabeled POVPC suppresses protein labeling by BY-POVPE.
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cell lysate. A similar observation was made with a biotin-tagged oxi-
dized phospholipid mixture in HAECs [34]. We suppose that this selec-
tivity is not due to speciﬁc molecular recognition but rather due to
differences in the pK values of the individual amino groups of the target
proteins. This value is inﬂuenced by surface exposure and interaction
withmembrane lipids and proteins in the immediate vicinity. A detailed
analysis of the labeled target candidates led to the identiﬁcation of pro-
teins involved in cell death and survival, stress response, transport and
lipid metabolism. There is some overlap between the protein targets
detected by the biotin-tagged probes [34] and the ﬂuorescent POVPC
analog. However, many other proteins identiﬁed in our studies have
not been reported in literature so far.
Protein modiﬁcation by POVPC may lead to activation of apoptotic
signaling components, as well as suppression of functions that help
the cell survive. Here, we would like to put the emphasis on the po-
tential roles of some target candidates that seem particularly relevant
to POVPC-induced apoptosis. Cathepsin D, caspase 1 and caspase 3 are
components of programmed cell death. Cathepsin D is a lysosomal
protease which is also associated with endosomal membranes [37].
Reactive oxygen species, oxidized proteins and lipids have already
been shown to activate this enzyme and increase the level of p53which is a transcription factor for cathepsin D. Activation of this pro-
tease leads to cytochrome c release from mitochondria, caspase 3 ac-
tivation and cell death [38]. Heat shock protein Hsp70B is expressed
and released by macrophages in response to oxidized LDL which is a
carrier of oxidized phospholipids. This protein plays a key role in
the activation of macrophages and helps the cells survive under oxi-
dative stress [39]. Calcium channels have also been identiﬁed as tar-
gets of oxidized phospholipids and play a role in atherosclerosis
[40]. Voltage dependent anion channel 1 (VDAC 1) is involved in
mitochondria-mediated apoptosis by regulating cytochrome c release
[41]. Minimally oxidized LDL rich in oxidized phospholipids induces
formation of reactive oxygen species leading to proinﬂammatory cy-
tokine expression. This process also depends on a target identiﬁed
in this study, namely spleen tyrosine kinase. Bae et al. found that
this enzyme is activated by mmLDL downstream of TLR 4 leading to
ROS generation in macrophages [42]. TLR 4 signaling is inhibited by
oxidized phospholipids [43], due to disruption of lipid rafts in the
plasma membrane. This phenomenon is in line with results from sin-
gle molecule ﬂuorescence microscopy showing that ﬂuorescent oxi-
dized phospholipids (PGPC) partition into lipid raft-like membrane
domains (caveolae) [24]. In this context, it is interesting to note that
stomatin has also been identiﬁed as a POVPC target. This protein
717U. Stemmer et al. / Biochimica et Biophysica Acta 1821 (2012) 706–718belongs to a larger family of polypeptides sharing an evolutionary con-
served stomatin/prohibitin/ﬂotillin/HﬂK/C domain [44]. It is known
from studies on epithelial cells [45], erythrocytes [46] and platelet alpha
granules [47] that it is a major raft component. N-acyl-sphingosine
hydrolase (ceramidase) and sphingosine phosphate lyase are also
potential POVPC targets. They are involved in sphingolipid metabo-
lism and inﬂuence the ceramide concentrations and cell susceptibil-
ity to apoptosis [48].
We and others provide evidence that head group-labeled POVPE is
a reliable analog of POVPC in biological systems. Fig. 7 shows that
POVPC suppresses protein modiﬁcation by BY-POVPE. Moumtzi et
al. found that ﬂuorescent and unlabeled oxPL elicited the same
rapid activation of acid sphingomyelinase in cultured cells. Lipid lo-
calization in the cells was the same irrespective of the lipid-bound
label [11]. Gugiu et al. studied the cellular protein targets of oxidized
phospholipids labeled with biotin at their head groups. They did not
ﬁnd any effects on biological lipid activities (competition experi-
ments with unlabeled lipids, stimulation of interleukin 8 formation)
[34]. Berliner et al. studied different oxidized phospholipid classes
and found that their biological activities mainly depended on the ox-
idized sn-2 acyl chain, but not on the polar head group [33].
We have preliminary evidence that POVPC forms covalent adducts
not only with proteins but also with aminophospholipids in cell mem-
branes. Incubation of BY-POVPEwith cultured cells led to the formation
of two new ﬂuorescent phospholipids with lower polarity. The struc-
tures of these compounds are currently subject to identiﬁcation.Fig. 8. Exchange of BY-POVPE between lipid–protein surfaces.OxPL, including POVPC, may be
systems are lipid aggregates (aqueous lipid suspension), complexes with proteins (BSA) and
pholipids and proteins. Despite the fact that the oxPL is ﬁrmly bound to these molecules (se
POVPC is easily released from its albumin complex and to a lower extent from its LDL comple
covalently bound aldehydo lipid can be explained by the pKs of aliphatic Schiff bases aroun
nucleophilic substitution by other amines. LDL showed the highest afﬁnity for POVPC bindin
be considered the main carrier for delivery of the oxPL to the cells.In summary, we have shown that ﬂuorescent analogs of PGPC and
POVPC are easily taken up into macrophages irrespective of the lipid
donor. Whereas POVPC is initially scavenged by covalent reaction
with the components of the plasma membrane, PGPC is quickly inter-
nalized. Despite the covalent binding to its lipid and protein targets,
POVPC is freely exchangeable between membranes and (lipo-) pro-
tein surfaces. As a consequence, this lipid represents a toxic com-
pound which is active not only at the site of its formation but also
in cells far distant from areas of oxidative stress (Fig. 8). The identiﬁ-
cation of the potential POVPC protein targets supports the assump-
tion that POVPC interacts with multiple sites and not only with the
traditional speciﬁc receptors.
The proteins identiﬁed in this study are target candidates for al-
kylation and functional modiﬁcation by the phospholipid aldehyde
POVPC. It is the aim of a current project to verify the function of
these proteins as primary targets and signaling platforms in macro-
phages under the conditions of oxidized phospholipid stress. For
this purpose, we are performing gain and loss of function studies as
well as FRET experiments to determine spatial lipid–protein proxim-
ity. These investigations could also help identify protein targets of the
carboxylate phospholipid PGPC that cannot be found using the prote-
ome approach described herein because this lipid does not covalently
bind to other biomolecules. These studies are expected to provide
new information on which target proteins represent primary signal-
ing platforms of cell death induced in macrophages by oxidized
phospholipids.bound to at least three physiologically relevant carriers. The respective supramolecular
lipoproteins (LDL). POVPC forms covalent Schiff bases with the amino groups of phos-
e Fig. 2), it is released to lipids and proteins of the cell plasma membrane. In addition,
x (see Figs. 3 and 4), too, if other lipid acceptors are present. The exchangeability of the
d pK 7. At this pK, a signiﬁcant fraction of the imine is protonated and thus subject to
g (accommodation in the phospholipids monolayer and binding by apoB) and can thus
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